JOA - 2026-11-12 - Journal Article
Association of Cutaneous Keloids and Hypertrophic Scarring with Risk of Postoperative Arthrofibrosis After Total Knee Arthroplasty.
Williams S, Ceballos-Alvarez KE, Mao E, Thakkar S
Topics
Key Takeaway
Patients with preoperative keloid or hypertrophic scarring history face a 2.06-fold increased odds of arthrofibrosis at 60 days and 1.74-fold increased odds of revision TKA at one year following primary TKA.
Summary Depth
Choose how much analysis to show on this article page.
Summary
This study used a large national database to determine whether a preoperative diagnosis of keloid or hypertrophic scarring predicts arthrofibrosis and related complications after primary TKA. After 1:1 propensity score matching on demographics and comorbidities, the keloid cohort showed significantly higher rates of arthrofibrosis at 60 days (OR 2.06), one year (OR 1.54), and two years (OR 1.55), along with elevated rates of MUA at all time points, revision TKA at one and two years (OR 1.74 and 1.50), and 30-day PJI (OR 2.05). No significant difference was found for lysis of adhesions or DVT.
Key Limitation
Arthrofibrosis diagnosis was defined by ICD coding without objective ROM criteria or clinical confirmation, making it impossible to distinguish true arthrofibrosis from coding artifacts or other causes of stiffness.
Original Abstract
BACKGROUND
Arthrofibrosis is a debilitating postoperative complication and a leading cause of readmission, failure, and revision surgery. The purpose of this study was to assess the association between cutaneous keloids, hypertrophic scarring, and risk of arthrofibrosis after primary total knee arthroplasty (TKA).
METHODS
Patients undergoing TKA (n = 248,094) were identified using a large national database. Exclusions included a TKA for fracture, post-traumatic osteoarthritis, rheumatoid arthritis, or congenital deformity, or a second TKA within two years. Remaining patients were assigned to a keloid cohort (prior diagnoses of hypertrophic scarring, acne keloids, or scar fibrosis; n = 6,307) and matched 1:1 to controls by demographics and comorbidities. After propensity score matching, 6,305 patients remained per cohort with no significant baseline differences. Outcomes were compared using Chi-square tests at 30 days, 60 days, one year, and two years postoperatively, with significance set at P < 0.0083 (0.05 of 6).
RESULTS
The Keloid cohort demonstrated significantly higher rates of arthrofibrosis at 60 days (odds ratio (OR) = 2.06, P < 0.001), one year (OR = 1.54, P < 0.001), and two years (OR = 1.55, P < 0.001); revision TKA at one year (OR = 1.74, P = 0.002), and two years (OR = 1.50, P = 0.006); manipulation under anesthesia at 60 days, one year, and two years (P < 0.001); and periprosthetic joint infection within 30 days (OR = 2.05, P < 0.001). There were no significant associations found for lysis of adhesions or deep vein thrombosis (DVT).
CONCLUSION
Patients who had preoperative cutaneous keloids or hypertrophic scarring demonstrate significantly higher rates of arthrofibrosis, revision TKA, manipulation under anesthesia, and periprosthetic joint infection following primary TKA. A dermatologic history of keloids and hypertrophic scarring may serve as a risk factor for identifying high-risk TKA patients.